Financhill
Sell
29

ZTS Quote, Financials, Valuation and Earnings

Last price:
$155.96
Seasonality move :
8.19%
Day range:
$151.01 - $156.62
52-week range:
$139.70 - $200.33
Dividend yield:
1.24%
P/E ratio:
27.40x
P/S ratio:
7.36x
P/B ratio:
14.07x
Volume:
4.1M
Avg. volume:
3M
1-year change:
-7.4%
Market cap:
$67.1B
Revenue:
$9.3B
EPS (TTM):
$5.47
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $6.7B $7.8B $8.1B $8.5B $9.3B
Revenue Growth (YoY) 6.63% 16.49% 3.91% 5.74% 8.33%
 
Cost of Revenues $2.1B $2.3B $2.5B $2.6B $2.7B
Gross Profit $4.6B $5.5B $5.6B $6B $6.5B
Gross Profit Margin 69.18% 70.38% 69.63% 70.03% 70.63%
 
R&D Expenses $463M $508M $539M $614M $686M
Selling, General & Admin $1.7B $2B $2B $2.2B $2.3B
Other Inc / (Exp) -$54M -$97M -$101M $1M -$140M
Operating Expenses $2.3B $2.7B $2.7B $2.9B $3.1B
Operating Income $2.3B $2.8B $2.9B $3.1B $3.4B
 
Net Interest Expenses $219M $218M $171M $134M $119M
EBT. Incl. Unusual Items $2B $2.5B $2.7B $2.9B $3.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $360M $454M $545M $596M $637M
Net Income to Company $1.6B $2B $2.1B $2.3B $2.5B
 
Minority Interest in Earnings $2M $3M $3M $4M -$10M
Net Income to Common Excl Extra Items $1.6B $2B $2.1B $2.3B $2.5B
 
Basic EPS (Cont. Ops) $3.44 $4.29 $4.51 $5.08 $5.47
Diluted EPS (Cont. Ops) $3.42 $4.27 $4.49 $5.07 $5.47
Weighted Average Basic Share $475.5M $474.3M $468.9M $461.2M $454.2M
Weighted Average Diluted Share $478.6M $476.7M $470.4M $462.3M $454.8M
 
EBITDA $2.7B $3.2B $3.3B $3.7B $3.9B
EBIT $2.2B $2.7B $2.9B $3.2B $3.4B
 
Revenue (Reported) $6.7B $7.8B $8.1B $8.5B $9.3B
Operating Income (Reported) $2.3B $2.8B $2.9B $3.1B $3.4B
Operating Income (Adjusted) $2.2B $2.7B $2.9B $3.2B $3.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.9B $2B $2B $2.2B $2.2B
Revenue Growth (YoY) 21.97% 6.15% 0.71% 9.5% 1.37%
 
Cost of Revenues $549M $569M $588M $643M $622M
Gross Profit $1.3B $1.4B $1.4B $1.5B $1.6B
Gross Profit Margin 70.66% 71.35% 70.6% 70.64% 71.98%
 
R&D Expenses $118M $122M $142M $162M $157M
Selling, General & Admin $409M $465M $505M $547M $563M
Other Inc / (Exp) -$12M -$11M -$1M -$28M -$5M
Operating Expenses $567M $628M $684M $746M $752M
Operating Income $755M $789M $728M $801M $846M
 
Net Interest Expenses $56M $51M $30M $26M $31M
EBT. Incl. Unusual Items $687M $727M $697M $747M $810M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $129M $133M $146M $148M $179M
Net Income to Company $558M $594M $551M $599M $631M
 
Minority Interest in Earnings $1M $1M $1M -- --
Net Income to Common Excl Extra Items $559M $595M $552M $599M $631M
 
Basic EPS (Cont. Ops) $1.18 $1.26 $1.19 $1.31 $1.41
Diluted EPS (Cont. Ops) $1.17 $1.26 $1.19 $1.31 $1.41
Weighted Average Basic Share $475.5M $472.2M $463.5M $458M $447.6M
Weighted Average Diluted Share $477.9M $474.1M $464.6M $458.8M $448M
 
EBITDA $853M $894M $880M $931M $983M
EBIT $744M $780M $760M $805M $864M
 
Revenue (Reported) $1.9B $2B $2B $2.2B $2.2B
Operating Income (Reported) $755M $789M $728M $801M $846M
Operating Income (Adjusted) $744M $780M $760M $805M $864M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $7B $7.9B $8.1B $8.7B $9.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1B $2.3B $2.5B $2.6B $2.7B
Gross Profit $4.9B $5.6B $5.6B $6.1B $6.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $474M $512M $559M $634M $681M
Selling, General & Admin $1.7B $2.1B $2B $2.2B $2.3B
Other Inc / (Exp) -$71M -$96M -$91M -$26M -$117M
Operating Expenses $2.4B $2.7B $2.8B $3B $3.2B
Operating Income $2.5B $2.8B $2.9B $3.1B $3.4B
 
Net Interest Expenses $228M $213M $150M $130M $124M
EBT. Incl. Unusual Items $2.2B $2.5B $2.6B $3B $3.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $415M $458M $558M $598M $668M
Net Income to Company $1.8B $2.1B $2.1B $2.4B $2.5B
 
Minority Interest in Earnings $3M $3M $3M $3M -$10M
Net Income to Common Excl Extra Items $1.8B $2.1B $2.1B $2.4B $2.5B
 
Basic EPS (Cont. Ops) $3.73 $4.38 $4.44 $5.19 $5.58
Diluted EPS (Cont. Ops) $3.71 $4.36 $4.43 $5.19 $5.57
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.9B $3.2B $3.3B $3.7B $3.9B
EBIT $2.4B $2.7B $2.9B $3.2B $3.4B
 
Revenue (Reported) $7B $7.9B $8.1B $8.7B $9.3B
Operating Income (Reported) $2.5B $2.8B $2.9B $3.1B $3.4B
Operating Income (Adjusted) $2.4B $2.7B $2.9B $3.2B $3.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.9B $2B $2B $2.2B $2.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $549M $569M $588M $643M $622M
Gross Profit $1.3B $1.4B $1.4B $1.5B $1.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $118M $122M $142M $162M $157M
Selling, General & Admin $409M $465M $505M $547M $563M
Other Inc / (Exp) -$12M -$11M -$1M -$28M -$5M
Operating Expenses $567M $628M $684M $746M $752M
Operating Income $755M $789M $728M $801M $846M
 
Net Interest Expenses $56M $51M $30M $26M $31M
EBT. Incl. Unusual Items $687M $727M $697M $747M $810M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $129M $133M $146M $148M $179M
Net Income to Company $558M $594M $551M $599M $631M
 
Minority Interest in Earnings $1M $1M $1M -- --
Net Income to Common Excl Extra Items $559M $595M $552M $599M $631M
 
Basic EPS (Cont. Ops) $1.18 $1.26 $1.19 $1.31 $1.41
Diluted EPS (Cont. Ops) $1.17 $1.26 $1.19 $1.31 $1.41
Weighted Average Basic Share $475.5M $472.2M $463.5M $458M $447.6M
Weighted Average Diluted Share $477.9M $474.1M $464.6M $458.8M $448M
 
EBITDA $853M $894M $880M $931M $983M
EBIT $744M $780M $760M $805M $864M
 
Revenue (Reported) $1.9B $2B $2B $2.2B $2.2B
Operating Income (Reported) $755M $789M $728M $801M $846M
Operating Income (Adjusted) $744M $780M $760M $805M $864M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $3.6B $3.5B $3.6B $2B $2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1B $1.1B $1.2B $1.3B $1.3B
Inventory $1.6B $1.9B $2.3B $2.6B $2.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $366M $389M $365M $434M $377M
Total Current Assets $6.6B $6.9B $7.5B $6.3B $6B
 
Property Plant And Equipment $2.4B $2.6B $3B $3.4B $3.6B
Long-Term Investments -- -- -- -- --
Goodwill $2.7B $2.7B $2.7B $2.8B $2.7B
Other Intangibles $1.7B $1.5B $1.4B $1.3B $1.1B
Other Long-Term Assets $106M $111M $147M $206M $250M
Total Assets $13.6B $13.9B $14.9B $14.3B $14.2B
 
Accounts Payable $457M $436M $405M $411M $433M
Accrued Expenses $556M $710M $682M $683M $746M
Current Portion Of Long-Term Debt $604M -- $1.4B -- $1.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $93M $67M $97M $102M $125M
Total Current Liabilities $2.2B $1.8B $3.2B $1.9B $3.4B
 
Long-Term Debt $6.6B $6.6B $6.6B $6.6B $5.2B
Capital Leases -- -- -- -- --
Total Liabilities $9.8B $9.4B $10.5B $9.3B $9.5B
 
Common Stock $5M $5M $5M $5M $5M
Other Common Equity Adj -$730M -$764M -$817M -$839M -$940M
Common Equity $3.8B $4.5B $4.4B $5B $4.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $4M $1M -$2M -$6M --
Total Equity $3.8B $4.5B $4.4B $5B $4.8B
 
Total Liabilities and Equity $13.6B $13.9B $14.9B $14.3B $14.2B
Cash and Short Terms $3.6B $3.5B $3.6B $2B $2B
Total Debt $7.2B $6.6B $7.9B $6.6B $6.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $3.6B $3.1B $2.1B $2B $1.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1B $1.2B $1.2B $1.3B $1.4B
Inventory $1.7B $2.1B $2.6B $2.7B $2.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $367M $423M $411M $440M $430M
Total Current Assets $6.8B $6.8B $6.3B $6.4B $5.9B
 
Property Plant And Equipment $2.4B $2.7B $3.1B $3.5B $3.7B
Long-Term Investments -- -- -- -- --
Goodwill $2.7B $2.7B $2.7B $2.8B $2.7B
Other Intangibles $1.7B $1.4B $1.3B $1.3B $1.1B
Other Long-Term Assets $108M $129M $143M $227M $232M
Total Assets $13.8B $13.9B $13.8B $14.3B $14.1B
 
Accounts Payable $346M $402M $424M $405M $420M
Accrued Expenses $570M $610M $701M $691M $772M
Current Portion Of Long-Term Debt $604M $1.4B $3M -- $1.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $71M $99M $104M $89M $117M
Total Current Liabilities $2.1B $3B $1.9B $1.9B $3.4B
 
Long-Term Debt $6.6B $5.2B $6.6B $6.6B $5.2B
Capital Leases -- -- -- -- --
Total Liabilities $9.7B $9.2B $9.3B $9.3B $9.4B
 
Common Stock $5M $5M $5M $5M $5M
Other Common Equity Adj -$633M -$704M -$828M -$841M -$1B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3M -- -$3M -$6M --
Total Equity $4.1B $4.7B $4.5B $5.1B $4.7B
 
Total Liabilities and Equity $13.8B $13.9B $13.8B $14.3B $14.1B
Cash and Short Terms $3.6B $3.1B $2.1B $2B $1.7B
Total Debt $7.2B $6.6B $6.6B $6.6B $6.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $1.6B $2B $2.1B $2.3B $2.5B
Depreciation & Amoritzation $441M $448M $465M $491M $497M
Stock-Based Compensation $59M $58M $62M $60M $74M
Change in Accounts Receivable $74M -$155M -$137M -$102M -$61M
Change in Inventories -$346M -$366M -$486M -$361M -$40M
Cash From Operations $2.1B $2.2B $1.9B $2.4B $3B
 
Capital Expenditures $453M $477M $586M $732M $655M
Cash Acquisitions -$113M -$14M -$312M -$59M $285M
Cash From Investing -$572M -$458M -$883M -$777M -$315M
 
Dividends Paid (Ex Special Dividend) -$380M -$474M -$611M -$692M -$786M
Special Dividend Paid
Long-Term Debt Issued $1.2B -- $1.3B -- --
Long-Term Debt Repaid -$500M -$600M -- -$1.4B --
Repurchase of Common Stock -$250M -$743M -$1.6B -$1.1B -$1.9B
Other Financing Activities -$11M -$6M -$11M -$3M -$5M
Cash From Financing $123M -$1.9B -$904M -$3.1B -$2.7B
 
Beginning Cash (CF) $1.9B $3.6B $3.5B $3.6B $2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.7B -$107M $125M -$1.5B -$22M
Ending Cash (CF) $3.6B $3.5B $3.6B $2B $2B
 
Levered Free Cash Flow $1.7B $1.7B $1.3B $1.6B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $558M $594M $551M $599M $631M
Depreciation & Amoritzation $109M $114M $120M $126M $119M
Stock-Based Compensation $13M $16M $9M $18M $17M
Change in Accounts Receivable -$108M -$102M $27M -$12M -$53M
Change in Inventories -$84M -$146M -$235M -$98M -$85M
Cash From Operations $400M $309M $549M $595M $587M
 
Capital Expenditures $77M $115M $223M $140M $149M
Cash Acquisitions -$3M -$4M -$7M -- --
Cash From Investing -$63M -$118M -$216M -$131M -$175M
 
Dividends Paid (Ex Special Dividend) -$119M -$154M -$174M -$198M -$224M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $1M $21M --
Long-Term Debt Repaid -- -- -$1.4B -- --
Repurchase of Common Stock -$181M -$361M -$283M -$339M -$443M
Other Financing Activities -- -- -- -- -$1M
Cash From Financing -$339M -$545M -$1.8B -$524M -$677M
 
Beginning Cash (CF) $3.6B $3.5B $3.6B $2B $2B
Foreign Exchange Rate Adjustment -- $4M -$3M -$6M -$1M
Additions / Reductions -$2M -$354M -$1.5B -$60M -$265M
Ending Cash (CF) $3.6B $3.1B $2.1B $2B $1.7B
 
Levered Free Cash Flow $323M $194M $326M $455M $438M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.8B $2.1B $2.1B $2.4B $2.5B
Depreciation & Amoritzation $440M $453M $471M $497M $490M
Stock-Based Compensation $56M $61M $55M $69M $73M
Change in Accounts Receivable -$143M -$149M -$8M -$141M -$102M
Change in Inventories -$333M -$428M -$575M -$224M -$27M
Cash From Operations $2.1B $2.1B $2.2B $2.4B $2.9B
 
Capital Expenditures $436M $515M $694M $649M $664M
Cash Acquisitions -$110M -$15M -$315M -$52M $285M
Cash From Investing -$578M -$513M -$981M -$692M -$359M
 
Dividends Paid (Ex Special Dividend) -$404M -$509M -$631M -$716M -$812M
Special Dividend Paid
Long-Term Debt Issued -- -- $1.3B -- --
Long-Term Debt Repaid -- -- -$1.4B -- --
Repurchase of Common Stock -$181M -$923M -$1.5B -$1.1B -$2B
Other Financing Activities -- -- -- -- -$6M
Cash From Financing $112M -$2.1B -$2.2B -$1.8B -$2.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.7B -$459M -$990M -$124M -$227M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.7B $1.6B $1.5B $1.8B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $558M $594M $551M $599M $631M
Depreciation & Amoritzation $109M $114M $120M $126M $119M
Stock-Based Compensation $13M $16M $9M $18M $17M
Change in Accounts Receivable -$108M -$102M $27M -$12M -$53M
Change in Inventories -$84M -$146M -$235M -$98M -$85M
Cash From Operations $400M $309M $549M $595M $587M
 
Capital Expenditures $77M $115M $223M $140M $149M
Cash Acquisitions -$3M -$4M -$7M -- --
Cash From Investing -$63M -$118M -$216M -$131M -$175M
 
Dividends Paid (Ex Special Dividend) -$119M -$154M -$174M -$198M -$224M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $1M $21M --
Long-Term Debt Repaid -- -- -$1.4B -- --
Repurchase of Common Stock -$181M -$361M -$283M -$339M -$443M
Other Financing Activities -- -- -- -- -$1M
Cash From Financing -$339M -$545M -$1.8B -$524M -$677M
 
Beginning Cash (CF) $3.6B $3.5B $3.6B $2B $2B
Foreign Exchange Rate Adjustment -- $4M -$3M -$6M -$1M
Additions / Reductions -$2M -$354M -$1.5B -$60M -$265M
Ending Cash (CF) $3.6B $3.1B $2.1B $2B $1.7B
 
Levered Free Cash Flow $323M $194M $326M $455M $438M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
52
SRPT alert for May 8

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 23.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock